誘導性多功能幹細胞市場：依細胞來源、應用、最終用戶和地區分類

Induced Pluripotent Stem Cells Market, By Cell Source, By Application, By End User, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，誘導性多功能幹細胞（iPS細胞）市場規模預計為17.83億美元，預計2033年將達到38.201億美元。預計2026年至2033年，該市場將以11.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	17.83億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.50%	2033年市場規模預測：	38.201億美元

誘導性多功能幹細胞（iPS細胞）是一種可以直接由成體細胞生成的多功能細胞。誘導性多功能幹細胞的發現徹底改變了再生醫學領域，為胚胎幹細胞提供了更符合倫理的替代方案。誘導性多功能幹細胞（iPS細胞）是經過基因重編程的成體細胞，使其恢復到類似胚胎幹細胞的多功能狀態。 iPS細胞被用於再生醫學研究，旨在闡明疾病機制、藥物研發和多功能篩檢。 iPS細胞的再生能力拓展了細胞治療方法開發的可能性。這些細胞是透過引入或過度表現關鍵轉錄因子，使原本分化的成體細胞恢復到類似胚胎幹細胞的狀態，從而獲得分化潛能和多能性標記物的表達。這項技術對於開發用於藥物發現、毒性篩檢和再生醫學的患者和疾病特異性幹細胞模型具有巨大的前景。

市場動態

全球誘導多能幹細胞（iPS細胞）市場成長的主要促進因素包括慢性疾病盛行率上升、器官移植數量增加以及生物製藥公司在開發新型幹細胞治療方法不斷加大研發投入。然而，iPS細胞研究和臨床應用的高成本，以及細胞再程式化和幹細胞分化的技術挑戰，限制了市場的進一步成長。另一方面，幹細胞技術的持續進步，例如標準培養方法的建立、無異質成分再程式化方法的開發以及大規模幹細胞生產的進展，有望為市場相關人員帶來可觀的成長機會。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球誘導多功能細胞（iPS 細胞）市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務績效和策略。
本調查涵蓋的主要公司包括 Takara Bio Inc.、Thermo Fisher Scientific、 FUJIFILM Holdings Corporation、 Astellas Pharma、Fate Therapeutics、Ncardia、ViaCyte、Cellular Dynamics International、Lonza、Blueprint Medicines 等主要企業。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球 iPS 細胞市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過用於分析全球 iPS 細胞市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- Takara Bio Inc.
- Thermo Fisher Scientific
- Fujifilm Holdings Corporation
- Astellas Pharma
- Fate Therapeutics
- Ncardia
- ViaCyte
- Cellular Dynamics International
- Lonza
- Blueprint Medicines
- Other Prominent Players
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6630

Induced Pluripotent Stem Cells Market is estimated to be valued at USD 1,783.0 Mn in 2026 and is expected to reach USD 3,820.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,783 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.50%	2033 Value Projection:	USD 3,820.1 Mn

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternative to embryonic stem cells. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like pluripotent state. iPSCs are used in regenerative medicine research to study mechanisms of disease and for drug discovery and toxicity screening. Regenerative properties of iPSCs provide opportunities for developing cell-based therapies. These cells are reprogrammed from their original differentiated adult cells through the introduction or overexpression of key transcription factors that enable them to regress to a state that resembles embryonic stem cells in terms of differentiation potential and expression of pluripotency markers. This technology holds tremendous promise for developing patient and disease specific stem cell models for drug discovery, toxicity screening, and regenerative therapies.

Market Dynamics

Global induced pluripotent stem cells market is driven by rising prevalence of chronic diseases, increasing adoption of organ transplantation and growing research and development (R&D) investments by biopharmaceutical companies for developing novel stem cell-based therapies. However, high costs that are associated with iPSC research and clinical applications, technical challenges in cell reprogramming and stem cell differentiation are restraining wider market growth. Meanwhile, ongoing advancements in stem cell technologies including establishment of standard culture practices, development of xeno-free reprogramming methods and progress in large-scale stem cell production are expected to offer lucrative growth opportunities for market players.

Key features of the study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global induced pluripotent stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines, and Other Prominent Players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global induced pluripotent stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global induced pluripotent stem cells market.

Market Segmentation

By Cell Source (Revenue, USD Mn, 2021 - 2033)
Skin derived iPSCs
Blood derived iPSCs
Urine Derived iPSCs
Hepatocytes derived iPSCs
Lung fibroblast derived iPSCs
Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
By Application (Revenue, USD Mn, 2021 - 2033)
Culture & Maintenance
Differentiation
Genetic Manipulation & Engineering
Characterization & Validation
Banking & Storage
Others (Reprogramming kits, Analysis software etc.)
By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Diagnostics Centers
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others (Academic & Research Institutes etc.)
By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global Induced Pluripotent Stem Cells Market
Takara Bio Inc.
Thermo Fisher Scientific
Fujifilm Holdings Corporation
Astellas Pharma
Fate Therapeutics
Ncardia
ViaCyte
Cellular Dynamics International
Lonza
Blueprint Medicines
Other Prominent Players

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Induced Pluripotent Stem Cells Market Snippet, By Cell Source
- Global Induced Pluripotent Stem Cells Market Snippet, By Application
- Global Induced Pluripotent Stem Cells Market Snippet, By End User
- Global Induced Pluripotent Stem Cells Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Induced Pluripotent Stem Cells Market, By Cell Source, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Skin derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Blood derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Urine Derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Hepatocytes derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Lung fibroblast derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

5. Global Induced Pluripotent Stem Cells Market, By Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Culture & Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Differentiation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Genetic Manipulation & Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Characterization & Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Banking & Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Others (Reprogramming kits, Analysis software etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

6. Global Induced Pluripotent Stem Cells Market, By End User, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
Others (Academic & Research Institutes etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

7. Global Induced Pluripotent Stem Cells Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profile
- Takara Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fujifilm Holdings Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fate Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ncardia
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ViaCyte
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cellular Dynamics International
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lonza
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Blueprint Medicines
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Other Prominent Players
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views